Options traders are at their most defensive in a year on DOW. That's happening while the lending market moves in the opposite direction — with short sellers actively reducing exposure.
The divergence tells a clear story about where the tension now sits in Dow Inc.
The put/call ratio closed at 1.125 on June 4. That's near the 52-week high of 1.147, touched on June 1. The 20-day mean sits at 1.024. The PCR has held above 1.10 for five consecutive sessions — a sustained defensive posture, not a one-day spike.
The stock has fallen 14.3% over the past month to $34.79. The options market is reflecting that damage. Protective put demand continues to outpace bullish call buying. That pattern began in mid-May and has not reversed.
Here's what's changed since the May 27 note: short interest has fallen, not risen. SI now stands at 3.16% of free float — down roughly 10% from peaks seen around mid-May, when it briefly exceeded 25 million shares.
The cost to borrow has collapsed. It stood at 0.41% on June 1. By June 4, it had dropped to 0.18% — a 55.8% weekly decline and the lowest level in the tracked period. That signals reduced demand from would-be shorts.
Availability confirms the picture. More than 7,373% of short interest is available to borrow. For every share currently shorted, there are roughly 73 shares sitting idle in the lending pool. The borrow market is exceptionally loose.
Short sellers are not pressing the trade despite a falling stock. The ORTEX short score has drifted lower, reaching 31.9 — consistent with reduced short-side conviction.
Citigroup cut its price target on May 27 from $48 to $41, maintaining its Buy rating. Argus Research upgraded to Buy from Hold on May 13. The mean analyst target sits at $42.63 — implying roughly 22% upside from current levels.
The analyst rec divergence factor score sits at the 95th percentile. That's a wide gap between where the stock trades and where the Street thinks it should be. Whether that reflects opportunity or anchoring to stale models is the live debate.
Capital Research added 5.65 million shares as of May 29. AQR built a 9 million share position. Both suggest some institutional buyers see value at these levels.
The next earnings event is July 23. Between now and then, the signal to track is whether the PCR begins to fade. Options defensiveness without a corresponding rise in short interest suggests hedgers rather than outright bears. If the PCR reverts toward its 20-day mean as the stock stabilises, it would indicate the defensive phase is passing. If it stays elevated or climbs toward the 1.147 high, caution remains the dominant posture.
See the live data behind this article on ORTEX.
Open DOW on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
